H.R.107: To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.

About This Bill

Bill Version

Bill Summary

This bill terminates certain limitations regarding drug rebates under Medicaid. Currently, the maximum rebate that drug manufacturers must pay under Medicaid for single-source and innovator multiple-source drugs is 100% of the average manufacturer price of the drug. The bill specifies that this limitation only applies to rebate periods that begin before January 1, 2020.

(Source: Library of Congress)

Bill Actions

Date Description
Jan. 31, 2019
Referred to the Subcommittee on Health.
Jan. 25, 2019
Referred to the Subcommittee on Health.
Jan. 3, 2019
Referred to the House Committee on Energy and Commerce.
Jan. 3, 2019

Introduced in the House by Michael C. Burgess (R-Texas)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page